ラテラルフロー免疫測定法（LFIA）ベースの迅速検査の世界市場レポート 2025年

ラテラルフロー免疫測定法（LFIA）ベースの迅速検査の市場規模は、今後数年間で安定した成長が見込まれます。2029年には年間平均成長率（CAGR）3.5％で83億米ドルに成長します。予測期間における減少は、世界のサプライチェーンの混乱、規制上の課題、競合の増加、代替技術の出現、デジタルヘルスプラットフォームとの統合などに起因すると考えられます。予測期間における主な動向としては、複数回または反復的なLFIAベースの迅速検査や結果の保存・伝達のための先進技術の開発、パートナーシップや共同研究への注力、在宅検査キットの開発、疾患のスクリーニングと検出のための人工知能ベースの検査への投資、患者が低コストで簡単に入手できる低価格検査キットの開発などが挙げられます。

品質管理は、ラテラルフロー免疫測定（LFIA）迅速検査市場の成長を妨げると予想される重要な課題であり続けています。給与や技術投資を含む運営コストの上昇は、多くの企業の利益率を圧迫しています。例えば、2023年6月、米国の非営利団体PLOSの報告書は、市場で入手可能なLFIA製品が一貫して高い信頼性と特異性の基準を満たしていないことを強調しました。4つのLFIA検査のレトロスペクティブ評価では、診断性能にかなりのばらつきがあることが示され、IgG検出の正確率が47％と低い検査もあった。

ラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場は、慢性疾患の有病率の増加によって成長することが予想されます。これらの長期的な健康状態には、早期発見、ポイントオブケア検査、定期的なモニタリングが必要であり、LFIAベースの迅速検査は迅速な結果を提供し、慢性疾患の管理に役立ちます。世界保健機関（WHO）の報告によると、非感染性疾患（NCDs）に起因する死亡者数は毎年相当数に上り、心血管疾患、がん、慢性呼吸器疾患、糖尿病などの疾患への対応におけるLFIAの役割が強調されています。このように、市場は慢性疾患の罹患率の上昇によって刺激されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ラテラルフロー免疫測定法（LFIA）ベースの迅速検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：成長率分析
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場の実績：規模と成長, 2019-2024
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界ラテラルフロー免疫測定法（LFIA）ベースの迅速検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 競合アッセイ
• サンドイッチアッセイ
• マルチプレックス検出アッセイ
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 妊娠と生殖
• 毒物学
• 心臓マーカーとコレステロール検査
• その他の用途
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院・クリニック
• 診断検査室
• ホームケア
• その他のエンドユーザー
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場競合アッセイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接競合アッセイ
• 間接競合アッセイ
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場サンドイッチアッセイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルステップサンドイッチアッセイ
• 2段階サンドイッチアッセイ
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場、マルチプレックス検出アッセイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マルチアナライトアッセイ
• さまざまなターゲットの同時検出

第7章 地域別・国別分析

• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：競合情勢
• ラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens AG
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• Hologic, Inc.
• LTEK Co., Ltd.
• JOYSBIO Biotechnology
• Jiangsu Medomics Medical Technologies
• Diagnocure
• Ubio Biotechnology Systems
• Elabscience（R）Immunoassay Kits
• FyoniBio/Glycotope GmbH
• Atomo Diagnostics Limited
• INDICAL Bioscience
• Lionex Gmbh

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場2029：新たな機会を提供する国
• ラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場2029：新たな機会を提供するセグメント
• ラテラルフロー免疫測定法（LFIA）ベースの迅速検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The rapid test based on Lateral Flow Immunoassay (LFIA) is a straightforward technology-driven diagnostic device employed for detecting the presence of specific targets, such as pathogens or biomarkers, in samples obtained from the human body. These samples encompass various bodily fluids such as urine, saliva, blood, and sweat.

The primary techniques include the competitive assay, sandwich assay, and multiplex detection assay. The competitive assay specifically determines the presence of targets, such as pathogens or biomarkers, within the collected samples. Its applications span infectious diseases, pregnancy and fertility assessments, toxicology, and others, making it applicable in diverse settings such as hospitals, clinics, diagnostic laboratories, home care, and more.

The lateral flow immunoassay (LFIA) based rapid test market research report is one of a series of new reports from The Business Research Company that provides lateral flow immunoassay (LFIA) based rapid test market statistics, including lateral flow immunoassay (LFIA) based rapid test industry global market size, regional shares, competitors with a lateral flow immunoassay (LFIA) based rapid test market share, detailed lateral flow immunoassay (LFIA) based rapid test market segments, market trends and opportunities, and any further data you may need to thrive in the lateral flow immunoassay (LFIA) based rapid test industry. This lateral flow immunoassay (LFIA) based rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow immunoassay (LFIA) based rapid test market size has declined steeply in recent years. It decline grow from $8.03 billion in 2024 to $7.23 billion in 2025 at a compound annual growth rate (CAGR) of -9.9%. The decline in the historic period can be attributed to limited sensitivity and specificity, complexity of multiplexing, cross-reactivity issues, storage and shelf-life challenges, limited quantitative capability.

The lateral flow immunoassay (LFIA) based rapid test market size is expected to see steady growth in the next few years. It will grow to $8.3 billion in 2029 at a compound annual growth rate (CAGR) of 3.5%. The decline in the forecast period can be attributed to global supply chain disruptions, regulatory challenges, increased competition, emergence of alternative technologies, integration with digital health platforms. Major trends in the forecast period include developing advanced technologies for multiple or repetitive LFIA based rapid test and storage/ communication of results, focus on partnerships and collaborations, develop at home test kits, invest in artificial intelligence-based tests for diseases screening and detection, and should develop low-cost test kits for easy access to patients at low cost.

Quality control continues to be a significant challenge anticipated to impede the growth of the lateral flow immunoassay (LFIA) rapid test market. Rising operational costs, encompassing salaries and technology investments, have strained profit margins for numerous firms. For example, in June 2023, a report from PLOS, a US-based non-profit organization, highlighted that LFIA products available in the market do not consistently adhere to high standards of reliability and specificity. A retrospective assessment of four LFIA tests indicated considerable variability in diagnostic performance, with some tests demonstrating accuracy rates as low as 47% for IgG detection.

The lateral flow immunoassay (LFIA) based rapid test market is set to experience growth fueled by the increasing prevalence of chronic diseases. These long-term health conditions demand early detection, point-of-care testing, and regular monitoring, with LFIA-based rapid tests offering prompt results and aiding in the management of chronic diseases. The World Health Organization reports a significant number of deaths attributed to non-communicable diseases (NCDs) annually, emphasizing the role of LFIA in addressing conditions such as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. The market is thus stimulated by the rising incidence of chronic diseases.

Major companies in the lateral flow immunoassay (LFIA)-based rapid test market are concentrating on technologies like qPCR (quantitative polymerase chain reaction) to improve the sensitivity and specificity of their tests, accelerate detection speed, and broaden the range of pathogens or biomarkers that can be identified. This focus aims to lead to more reliable and accurate diagnostic solutions for various healthcare applications. qPCR technology is a molecular biology method used to amplify and quantify DNA or RNA sequences in real time, allowing for precise measurements of gene expression levels or the detection of specific pathogens in various samples. For example, in November 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced the LightCycler PRO System. This system builds on Roche's legacy of qPCR technologies, employing gold-standard techniques to ensure high quality, precision, and reliability-capabilities that are vital for accurate patient diagnosis and effective clinical decision-making.

Leading companies in the lateral flow immunoassay (LFIA)-based rapid test market are also investing in Integrated Health Solutions to enhance diagnostic efficiency, optimize workflows, and deliver comprehensive patient care through improved data sharing and collaboration across healthcare platforms. Integrated Health Solutions encompass comprehensive healthcare systems that link various services, technologies, and data to enhance patient care and streamline operations. For instance, in June 2024, F. Hoffmann-La Roche AG launched analytical units for its Cobas Pro integrated solutions. The Cobas Pro system can process up to 1,000 samples per hour with its sample supply unit and features high-speed analytical units capable of conducting up to 900 tests per hour for the ion-selective electrode (ISE) and 1,000 tests per hour for the Cobas C 503 unit, which specializes in clinical chemistry.

In August 2023, Danaher Corporation acquired Abcam plc for $5.7 billion, aligning with Danaher's strategy to bolster its life sciences business. The acquisition of Abcam, a UK-based biotechnology company specializing in LFIA-based rapid tests, is expected to enhance value for shareholders and deliver outstanding results for both the workforce and clients.

Major companies operating in the lateral flow immunoassay (LFIA) based rapid test market include Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., Hologic, Inc., LTEK Co., Ltd., JOYSBIO Biotechnology, Jiangsu Medomics Medical Technologies, Diagnocure, Ubio Biotechnology Systems, Elabscience(R) Immunoassay Kits, FyoniBio / Glycotope GmbH, Atomo Diagnostics Limited, INDICAL Bioscience, Lionex Gmbh, BIOMED Labordiagnostik GmbH, Charles River Laboratories, EKF Diagnostics, Launch Diagnostics, Diagnostic Instruments Ltd, Qiagen N.V., Merck KGaA, XPhyto Therapeutics, 3a Diagnostics, Roche Holding AG, BATM, Biomaxima, SensDx, Vitrosens Biotechnology, Bioeasy Biotechnology, Fujirebio, Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, CTK Biotech

North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2024. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lateral flow immunoassay (LFIA) based rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

Lateral Flow Immunoassay (LFIA) based rapid test market consists of sales of conjugate pads, nitrocellulose membrane and absorbent pad. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral flow immunoassay (lfia) based rapid test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lateral flow immunoassay (lfia) based rapid test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lateral flow immunoassay (lfia) based rapid test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
• 2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
• 3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
• Subsegments:
• 1) By Competitive Assay: Direct Competitive Assays; Indirect Competitive Assays
• 2) By Sandwich Assay: Single-step Sandwich Assays; Two-step Sandwich Assays
• 3) By Multiplex Detection Assay: Multi-analyte Assays; Simultaneous Detection Of Various Targets
• Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche; Quidel Corporation; Becton, Dickinson and Company; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Characteristics

3. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Trends And Strategies

4. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Growth Rate Analysis
• 5.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Total Addressable Market (TAM)

6. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

• 6.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Competitive Assay
• Sandwich Assay
• Multiplex Detection Assay
• 6.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease
• Pregnancy & Fertility
• Toxicology
• Cardiac Marker And Cholesterol Testing
• Other Applications
• 6.3. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital & Clinic
• Diagnostic Laboratory
• Home Care
• Other End Users
• 6.4. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Competitive Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Competitive Assays
• Indirect Competitive Assays
• 6.5. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Sandwich Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-step Sandwich Assays
• Two-step Sandwich Assays
• 6.6. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Sub-Segmentation Of Multiplex Detection Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-analyte Assays
• Simultaneous Detection Of Various Targets

7. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Regional And Country Analysis

• 7.1. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 8.1. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 9.1. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 9.2. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 10.1. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 11.1. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 11.2. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 12.1. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 13.1. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 14.1. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 14.2. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 15.1. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 15.2. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 16.1. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 17.1. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 18.1. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 19.1. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 20.1. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 21.1. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 21.2. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 22.1. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 23.1. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 23.2. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 24.1. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 24.2. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 25.1. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 25.2. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 26.1. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 26.2. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 27.1. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 28.1. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 28.2. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

• 29.1. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Overview
• 29.2. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape And Company Profiles

• 30.1. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Landscape
• 30.2. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Other Major And Innovative Companies

• 31.1. Siemens AG
• 31.2. Thermo Fisher Scientific Inc.
• 31.3. Bio-Rad Laboratories, Inc.
• 31.4. PerkinElmer Inc.
• 31.5. Hologic, Inc.
• 31.6. LTEK Co., Ltd.
• 31.7. JOYSBIO Biotechnology
• 31.8. Jiangsu Medomics Medical Technologies
• 31.9. Diagnocure
• 31.10. Ubio Biotechnology Systems
• 31.11. Elabscience(R) Immunoassay Kits
• 31.12. FyoniBio / Glycotope GmbH
• 31.13. Atomo Diagnostics Limited
• 31.14. INDICAL Bioscience
• 31.15. Lionex Gmbh

32. Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

34. Recent Developments In The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

35. Lateral Flow Immunoassay (LFIA) Based Rapid Test Market High Potential Countries, Segments and Strategies

• 35.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer